AB-CHMINACA : report on the risk assessment of N-(1amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide in the framework of the Council Decision on new psychoactive substances [PDF]
AB-CHMINACA : report on the risk assessment of N-(1amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide in the framework of the Council Decision on new psychoactive substances [PDF]
European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Lisbon: EMCDDA, 2018
67 p.
Risk assessments ;24
drugs - Nieuwe Psychoactieve Stoffen - productinformatie - onderzoeksrapporten - risicoschatting -
Exemplaarinformatie:
E-bron
Online link:
http://www.google.com/search?q=report-on-the-risk-assessment-of-N-1amino-3-methyl-1-oxobutan-2-yl-1cyclohexylmethyl-1H-indazole-3carboxamide Kies "toon normaal" voor een toonformaat met hyperlinks.
European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Lisbon: EMCDDA, 2018
67 p.
Risk assessments ;24
drugs - Nieuwe Psychoactieve Stoffen - productinformatie - onderzoeksrapporten - risicoschatting -
Exemplaarinformatie:
E-bron
Online link:
http://www.google.com/search?q=report-on-the-risk-assessment-of-N-1amino-3-methyl-1-oxobutan-2-yl-1cyclohexylmethyl-1H-indazole-3carboxamide Kies "toon normaal" voor een toonformaat met hyperlinks.